Prime Medicine (PRME) Current Assets (2021 - 2026)

Prime Medicine's Current Assets history runs 6 years deep, the most recent figure standing at $137.9 million for Q1 2026.

• Quarterly Current Assets fell 15.8% year-over-year to $137.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $137.9 million (down 15.8% YoY) and the FY2025 annual result came in at $181.3 million, down 14.44% from the prior year.
• Current Assets was $137.9 million for Q1 2026 at Prime Medicine, down from $181.3 million in the prior quarter.
• Across five years, Current Assets topped out at $296.6 million in Q4 2022 and bottomed at $121.3 million in Q2 2025.
• A 5-year average of $195.1 million and a median of $184.5 million in 2023 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2023 — Current Assets sank 51.8% — and 2024, when it soared 48.2%.
• Prime Medicine's Current Assets stood at $296.6 million in 2022, then sank by 51.8% to $143.0 million in 2023, then surged by 48.2% to $211.9 million in 2024, then slipped by 14.44% to $181.3 million in 2025, then slipped by 23.94% to $137.9 million in 2026.
• Business Quant data shows PRME's Current Assets at $137.9 million in Q1 2026, $181.3 million in Q4 2025, and $231.4 million in Q3 2025.